Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Sympathetic Activity in CKD
NCT01257009Phase 4Completed
- Start
- Aug 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in chronic kidney disease (CKD) and hypertension (HTN). Primary endpoint: Muscle Sympathetic Nerve Activity at 6 weeks. Started Aug 2009; status: completed.
02
Drugs
atorvastatin
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on NCT01257009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257009.